Issue link: http://catalog.e-digitaleditions.com/i/114936
MedSurg MedSurg products include surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical); and reprocessed and remanufactured medical devices as well as other medical device products used in a variety of medical specialties. The net sales of MedSurg products over the last three years were: Instruments Endoscopy Medical Other Total $ $ 2012 1,261 1,111 691 202 3,265 39 % $ 34 % 21 % 6% 100% $ 2011 1,187 1,080 722 171 3,160 38 % $ 34 % 23 % 5% 100% $ 2010 1,085 985 583 150 2,803 39 % 35 % 21 % 5% 100% In 2012 we launched System 7, the next generation of heavy duty surgical power tools. These tools are used in total joint procedures, such as hip and knee replacements, and offer the latest in advanced cutting technology. We also launched the 1488 HD 3-Chip Endoscopic Camera System, which utilizes advanced CMOS technology and premium optics to provide a clear bright image designed to enhance patient outcomes. In addition, we launched Power-LOADTM, our cot fastener system that lifts and lowers the cot into and out of ambulances, thereby reducing spinal loads and the risk of cumulative trauma injuries to emergency responders. In 2010 we acquired the assets used to produce the Sonopet Ultrasonic Aspirator control consoles, handpieces and accessories, which are used by surgeons to fragment soft and hard tissue for tumor removal and bone cutting and have applications in our Instruments product line. In 2010 we acquired Gaymar Industries (Gaymar), which specializes in support surfaces and pressure ulcer management solutions as well as the temperature management segment of the healthcare industry. Gaymar enhances the offerings in our Medical product line. Stryker is one of three market leaders in Instruments, competing principally with Medtronic, Inc. and Conmed Linvatec, Inc. (a subsidiary of CONMED Corporation) globally; internationally, we also compete with Aesculap-Werke AG (a division of B. Braun Melsungen AG). In Endoscopy, we compete with Smith & Nephew Endoscopy (a division of Smith & Nephew plc), ConMed Linvatec, Inc., Arthrex, Inc., Karl Storz GmbH & Co. and Olympus Optical Co. Ltd. Our primary competitors in Medical are HillRom Holdings, Inc. and Kinetic Concepts, Inc. Neurotechnology and Spine Our Neurotechnology and Spine products include a comprehensive portfolio of products including both neurosurgical and neurovascular devices. Our neurotechnology offering includes products used for minimally invasive endovascular techniques, as well as a comprehensive line of products for traditional brain and open skull base surgical procedures, orthobiologic and biosurgery products including synthetic bone grafts and vertebral augmentation products, as well as minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. We also develop, manufacture and market spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. The net sales of Neurotechnology and Spine products over the last three years were: Neurotechnology Spine Total $ $ 2012 842 727 1,569 54 % $ 46 % 100% $ 2011 750 687 1,437 52 % $ 48 % 100% $ 2010 320 648 968 33 % 67 % 100% In 2012 we received 510(k) approval to market the Trevo�� Pro Retriever, our next generation clot removal technology that utilizes proprietary Stentriever�� Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke. In 2012 we received 510(k) approval to market our Trevo�� ProVEUTM Retriever, the first clot removal device fully visible during the procedure for precise positioning within the clot and optimized clot retrieval in patients experiencing acute ischemic stroke. 2 Dollar amounts in millions except per share amounts or as otherwise specified